Latest Breaking News On - சிட்ரின் மருந்து - Page 1 : comparemela.com

RareStone Inc Announces Strategic Collaboration with Tencent on a Service Ecosystem Focused on Rare Disease Patients in China

RareStone Inc Announces Strategic Collaboration with Tencent on a Service Ecosystem Focused on Rare Disease Patients in China
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomMelissa bradford klugShawn xiangPain challenge charity foundationDuchenne muscular dystrophy mutual associationRarestone incHypercortisolism allianceTencent holdings limitedChina mucopolysaccharidosis typei patient alliancePrnewswire rarestone incStone incCitrine medicineBeijing pain challenge charity foundationDuchenne muscular dystrophy careShenzhen muscular dystrophy baby care

RareStone Inc Announces Submission of New Drug Application (NDA) of Wakix® (pitolisant) for narcolepsy with and without cataplexy in China

RareStone Inc Announces Submission of New Drug Application (NDA) of Wakix® (pitolisant) for narcolepsy with and without cataplexy in China
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomMelissa bradford klugRarestone incRarestone groupNational medical products associationPrnewswire rarestone incStone incCitrine medicineNew drug applicationChief business officerMedia contactஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்மெலிசா பிராட்போர்டு க்லக்தேசிய மருத்துவ ப்ராடக்ட்ஸ் சங்கம்

Milestone Payments Triggered following EC Approval

Milestone Payments Triggered following EC Approval
labmate-online.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from labmate-online.com Daily Mail and Mail on Sunday newspapers.

Hong kongUnited kingdomNational medical products administrationEuropean commissionDiurnal groupCitrine medicineGreater chinaNew drug applicationஹாங் காங்ஒன்றுபட்டது கிஂக்டம்ஐரோப்பிய தரகுசிட்ரின் மருந்துஅதிகமானது சீனாபுதியது மருந்து விண்ணப்பம்

Diurnal lines up $1 25 million payment from Citrine Medicine after meeting milestones | 1 June 2021

Diurnal lines up $1.25 million payment from Citrine Medicine after meeting milestones

European commissionDiurnal group plcCitrine medicineLon dnlInl lஐரோப்பிய தரகுசிட்ரின் மருந்து

Diurnal (AIM:DNL) | RNS | Diurnal Group PLC - Agreement with Citrine Medicine for Efmody

$1.0 million and will receive $28.75 million in additional cash payments upon achievement of certain regulatory milestones and sales milestones based on annual sales thresholds. Diurnal will also receive tiered royalties on sales ranging from low to mid double-digits. Citrine is a therapeutics platform company focused on the Greater China market that was co-founded by Vivo Capital, F-Prime Capital and Eight Roads Ventures. Citrine is focused on creating a therapeutic platform to deliver rare disease drugs to the Chinese market and to develop the first ever rare disease ecosystem in the country. The Company signed an original licensing agreement with Citrine in

United kingdomHong kongMelissa bradford klugFoster mitchellEmma earlFreddy crossleyMartin whitakerRichard bungayAlex davisRupert deardenSimon conwayCitrine medicine incPanmure gordon united kingdom limited nominated adviserDiurnal groupCitrine medicineVivo capital